Essity AB (ESSITY-B.ST) is a leading global hygiene and health company with brands like TENA, Libresse, and Tork. The company is undergoing a significant margin improvement program, targeting 15%+ EBITA margin by 2025, driven by cost savings, premiumization, and portfolio optimization. With a strong balance sheet and defensive consumer staples exposure, Essity offers a rare combination of growth and stability in the consumer compounders theme.
Investment Thesis
Essity is a market leader in tissue, feminine care, incontinence care, and professional hygiene. The company benefits from secular trends like aging populations (incontinence) and increasing hygiene awareness. After a period of margin compression due to input cost inflation, Essity is now seeing raw material costs normalize and is executing a restructuring program to improve efficiency. The spin-off of the Vinda business in Asia simplifies the portfolio and unlocks value. Valuation is attractive at ~15x forward P/E with a dividend yield of ~3%.
12-Month Catalysts
- Margin recovery: Cost savings program and lower pulp prices should drive EBITA margin expansion towards 15% target.
- Portfolio optimization: Continued divestitures of non-core assets and focus on higher-margin categories.
- Organic growth acceleration: Innovation in incontinence and professional hygiene segments.
Key Risks
- Raw material volatility: Pulp prices could spike again, pressuring margins.
- Competition: Intense competition from private labels and peers like Kimberly-Clark and Procter & Gamble.
Disclaimer: This is not financial advice. Please conduct your own due diligence before investing.